Amicus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
Amicus Therapeutics | DEFA14A: Others
Amicus Therapeutics | DEF 14A: Definitive information statements
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data